In 2023, Elena Levtchenko's group (Leuven, Belgium) transfected both mutant renal proximal tubular cells and podocytes from a cystinosis patient with a stabilized HA-tagged CTNS mRNA designed by RiboPro B.V. in the Netherlands. The gene discussed is CTNS; the disease is cystinosis.